NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference

Group 1 - The company Nanobiotix is participating in the Jefferies Global Healthcare Conference on June 5, 2025, where management will engage in fireside chats [1] - Bart van Rhijn, the Chief Financial & Business Officer of Nanobiotix, will be one of the presenters at the conference [1] - The event will be webcast live, and a replay will be available after the event [1] Group 2 - Nanobiotix is a late-stage clinical biotechnology company focused on innovative nanoparticle-based therapies for cancer and other major diseases [2] - The company is headquartered in Paris, France, and has been listed on Euronext Paris since 2012 and on Nasdaq since December 2020 [3] - Nanobiotix holds over 25 umbrella patents related to three nanotechnology platforms, which include applications in oncology, bioavailability, and disorders of the central nervous system [4]